Inovio Pharmaceuticals
INO
#9511
Rank
โ‚ฌ0.11 B
Marketcap
1,08ย โ‚ฌ
Share price
-3.08%
Change (1 day)
-48.64%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): -1,97ย โ‚ฌ

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,95ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,55ย โ‚ฌ an increase over its 2024 EPS that were of -3,39ย โ‚ฌ.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,97ย โ‚ฌ26.93%
2025-1,55ย โ‚ฌ-54.18%
2024-3,39ย โ‚ฌ-35.14%
2023-5,23ย โ‚ฌ-56.62%
2022-12,05ย โ‚ฌ-19.54%
2021-14,98ย โ‚ฌ35.9%
2020-11,02ย โ‚ฌ-11.57%
2019-12,46ย โ‚ฌ15.24%
2018-10,82ย โ‚ฌ-2.78%
2017-11,12ย โ‚ฌ6.93%
2016-10,40ย โ‚ฌ134.88%
2015-4,43ย โ‚ฌ-29.51%
2014-6,28ย โ‚ฌ-57.34%
2013-14,73ย โ‚ฌ146.55%
2012-5,97ย โ‚ฌ20.83%
2011-4,94ย โ‚ฌ-29.41%
2010-7,00ย โ‚ฌ-48.48%
2009-13,60ย โ‚ฌ10%
2008-12,36ย โ‚ฌ11.11%
2007-11,12ย โ‚ฌ-41.3%
2006-18,95ย โ‚ฌ-66.91%
2005-57,27ย โ‚ฌ110.61%
2004-27,19ย โ‚ฌ-61.63%
2003-70,87ย โ‚ฌ186.67%
2002-24,72ย โ‚ฌ
2001N/A-100%
2000-19,78ย โ‚ฌ-62.96%
1999-53,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,50ย โ‚ฌ-484.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,03ย โ‚ฌ-409.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1,12ย โ‚ฌ-157.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
6,37ย โ‚ฌ-426.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3,07ย โ‚ฌ-257.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,34ย โ‚ฌ-271.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
0,70ย โ‚ฌ-135.68%๐Ÿ‡บ๐Ÿ‡ธ USA